Florian Krammer focuses on Virology, Virus, Antibody, Influenza A virus and Hemagglutinin. His studies in Virology integrate themes in fields like Epitope and Immunology. His Virus research is multidisciplinary, incorporating perspectives in Pandemic and Immunity.
His Antibody study combines topics from a wide range of disciplines, such as T cell and Antigen. His Influenza A virus research includes elements of Recombinant DNA and Microbiology. His research in Hemagglutinin intersects with topics in Polyclonal antibodies, Antibody-dependent cell-mediated cytotoxicity, Cytotoxicity and In vivo.
Florian Krammer mostly deals with Virology, Virus, Antibody, Hemagglutinin and Vaccination. Florian Krammer has included themes like Epitope and Antigen in his Virology study. His Virus research incorporates elements of Pandemic, Monoclonal antibody and Immunity.
His Antibody study integrates concerns from other disciplines, such as Immune system and Severe acute respiratory syndrome coronavirus 2. The study incorporates disciplines such as Immunization, Antibody-dependent cell-mediated cytotoxicity, Microbiology, Hemagglutination assay and H5N1 genetic structure in addition to Hemagglutinin. His work on Live attenuated influenza vaccine as part of general Vaccination research is frequently linked to Heterosubtypic immunity, bridging the gap between disciplines.
His scientific interests lie mostly in Virology, Antibody, Virus, Severe acute respiratory syndrome coronavirus 2 and Coronavirus disease 2019. His studies deal with areas such as Epitope and Monoclonal antibody as well as Virology. Florian Krammer has researched Antibody in several fields, including Immune system, Antigen and Vaccination.
His research on Virus focuses in particular on Antigenic drift. His work carried out in the field of Severe acute respiratory syndrome coronavirus 2 brings together such families of science as Metropolitan area, Adverse effect, Spike Protein and Messenger RNA. His Hemagglutinin study incorporates themes from Hemagglutination assay, Influenza A virus and Antibody-dependent cell-mediated cytotoxicity.
His primary areas of investigation include Antibody, Severe acute respiratory syndrome coronavirus 2, Virology, Virus and Coronavirus disease 2019. His Antibody research integrates issues from CD8, Immune system and Antigen. Florian Krammer studied Severe acute respiratory syndrome coronavirus 2 and Pandemic that intersect with Immunity, Viral Epidemiology and Pneumonia.
He usually deals with Virology and limits it to topics linked to Serology and Betacoronavirus. His work in the fields of Virus, such as Vero cell and Hemagglutinin, overlaps with other areas such as Drug development. His Convalescent plasma study in the realm of Coronavirus disease 2019 connects with subjects such as State of the science and Current.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.
Alba Grifoni;Daniela Weiskopf;Sydney I. Ramirez;Sydney I. Ramirez;Jose Mateus.
Cell (2020)
A serological assay to detect SARS-CoV-2 seroconversion in humans.
Fatima Amanat;Daniel Stadlbauer;Shirin Strohmeier;Shirin Strohmeier;Thi H. O. Nguyen.
Nature Medicine (2020)
SARS-CoV-2 Vaccines: Status Report.
Fatima Amanat;Florian Krammer.
Immunity (2020)
Immunology of COVID-19: Current State of the Science.
Nicolas Vabret;Graham J. Britton;Conor Gruber;Samarth Hegde.
Immunity (2020)
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Qian Zhang;Paul Bastard;Paul Bastard;Zhiyong Liu;Jérémie Le Pen.
Science (2020)
Advances in the development of influenza virus vaccines.
Florian Krammer;Peter Palese.
Nature Reviews Drug Discovery (2015)
SARS-CoV-2 vaccines in development.
Florian Krammer.
Nature (2020)
Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity
Susana V. Bardina;Paul Bunduc;Shashank Tripathi;James Duehr.
Science (2017)
Chimeric Hemagglutinin Influenza Virus Vaccine Constructs Elicit Broadly Protective Stalk-Specific Antibodies
Florian Krammer;Natalie Pica;Rong Hai;Irina Margine.
Journal of Virology (2013)
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months.
Ania Wajnberg;Fatima Amanat;Adolfo Firpo;Deena R. Altman.
Science (2020)
Vaccine
(Impact Factor: 4.169)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
University of Chicago
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
Emory University
University of Rochester Medical Center
University of Rochester Medical Center
Emory University
Icahn School of Medicine at Mount Sinai
Zhejiang University
University of Ioannina
University of Southern California
University of Pavia
University of Milan
Peking University
Lawrence Berkeley National Laboratory
University of Central Florida
University of Bonn
University of Turin
The University of Texas at Arlington
University of Duisburg-Essen
University of Copenhagen
National Oceanic and Atmospheric Administration
University of Edinburgh
University of Vienna